Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.03.2024 | Case report

Buspirone/Citalopram/Nabilone

Lack of efficacy

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Garel N, et al. Ketamine for depression: a potential role in requests for Medical Aid in Dying?. International Clinical Psychopharmacology 38: 352-355, No. 5, Sep 2023. Available from: URL: 10.1097/YIC.0000000000000462 Garel N, et al. Ketamine for depression: a potential role in requests for Medical Aid in Dying?. International Clinical Psychopharmacology 38: 352-355, No. 5, Sep 2023. Available from: URL: 10.1097/YIC.0000000000000462
Metadaten
Titel
Buspirone/Citalopram/Nabilone
Lack of efficacy
Publikationsdatum
01.03.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-55119-8

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Clozapine

Case report

Multiple drugs